Home » Topics » BioWorld Science

BioWorld Science
RSS

JNK inhibitor appears to have disease-modifying activity in rheumatoid arthritis

July 25, 2001

Second-quarter development progress reported by Sepracor

July 25, 2001

Adaptive Screening offers new approach to drug discovery

July 25, 2001

Cell Matrix awarded grants for development of novel antiangiogenesis products

July 25, 2001

Diversa and IntraBiotics discontinue antimicrobial alliance

July 25, 2001

Investigational immunotherapy for Alzheimer's disease enters phase IIa

July 25, 2001

Neuroprotective agents designed at Nippon Kayaku attenuate paclitaxel-induced damage

July 24, 2001

Novel Genzyme intracellular delivery compounds particularly useful in gene therapy

July 24, 2001

Sankyo reveals naturally produced MPO inhibitors

July 24, 2001

Hydroxamic acid derivatives useful as antimicrobials

July 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...